Özet

Background: In this study, we present early and mid-term results of the combined use of multilayer flow modulator stent and conventional stent grafts in aortic aneurysms and Type B aortic dissections.

Methods: The files and computerized data of 78 patients who underwent endovascular stent graft implantation due to an aortic aneurysm and dissection in our clinic between January 2015 and December 2016 were retrospectively analyzed. Among these patients, six male patients (mean age 69.5 years; range 63 to 77 years) who were treated with multilayer flow modulator stents in combination with conventional stent grafts were included. A successful intervention was defined as the placement of the stents into the aneurysmatic region without any complications. The patients were followed for the development of any clinical events during 12 months.

Results: The common symptoms observed in the half of the patients were abdominal pain and back pain. One patient had claudication during walking. In all patients, the interventions were successfully completed and no mortality was observed in any patient. One of the patients developed Type 1 endoleak during the procedure; however, it was completely corrected using the aortic stent graft extension. Creatinine levels were elevated (2.1 mg/dL) in one patient on the second day of the operation. The patient did not require dialysis and the kidney functions completely returned to normal on the seventh day. No intra- or postoperative complications developed.

Conclusion: Multilayer flow modulator stents seem to be effective and safe in the treatment of aortic aneurysms with major side branches. The combined use of stents with different stent-graft devices increase the success rate and reduce the complication rate in complex aortic aneurysms.

Aneurysms of the aorta and peripheral arteries are uncommon clinical conditions. When not treated, they can grow in size and cause death due to rupture.[1] The treatment of a neurysms has been done by the open surgical approach since the early 1950s.[2] With developments in endovascular techniques for the past 20 years, percutaneous treatment methods have become an alternative to the surgery. Its areas of use are on the increase due to its contribution in shortened duration of intensive care and hospital stay, reduced blood loss and transfusion requirement, its application in patients with other system problems, and because it has a lower mortality and morbidity rate.[2,3]

Some special endovascular devices have been developed which can be used in the presence of complex aneurysms of major side branches within or near the aneurysmal sac. The best known of these are chimney stent grafts, fenestrated stent grafts,[3,4] and multilayer flow modulator (MFM) stents.[5,6] Unlike aneurysms, there are insufficient studies on the use of MFM stents in dissections. The use of stent grafts (coated stents) instead of MFM stents in the presence of dissection would be more appropriate.

Multilayer flow modulator stents are self-expanding, three-layered, high-radial strength and elastic, chromecobalt alloy containing, and bare structured stents which are not coated with any material. They have been developed for the treatment of aneurysms of the aorta and peripheral arteries. These multilayered stents change the flow dynamics along the vessel, converting the turbulent flow in the aneurysm sac into a laminar flow, and at the same time acting as a passive barrier by significantly reducing the flow (>90%). They provide thrombus formation in the aneurysmal sac and the size of the aneurysm shrinks with time. The laminar flow does not cause any deterioration in the continuity of flow in the lateral branches.[7]

In this study, early and midterm results of six patients who underwent conventional endovascular stent-grafts in combination with MFM stents were presented.

Yöntem

The patient files and computer data of 78 patients who underwent endovascular stent graft implantation for an aortic aneurysm and dissection in our clinic between January 2014 and December 2016 were retrospectively reviewed, after obtaining approval from the Ethics Committee. The study was carried out in accordance with the principles of the Declaration of Helsinki. The study inclusion criteria were a diameter of the aneurysm of at least 55 mm or an aneurysm accompanied by dissection, and the MFM stent and other conventional stents being used in the same patient. Six male patients (mean age 69.5 years; range 63 to 77 years) from the 78 patients who met these criteria were included in the study. Placement of the stent-grafts into the aneurysm region without complications was defined as a successful intervention.

The common symptom in half of the patients was abdominal pain and back pain. Claudication on walking was also reported in one patient. The other two patients were asymptomatic. Evaluation of the patients according to etiology demonstrated that there was at least one disease associated with a non-specific degenerative aneurysm and aortic pathology in all of the patients. Two patients had Type B dissection according to Stanford classification, hypertension in four patients, diabetes mellitus in two patients, coronary artery disease and hyperlipidemia in two patients, while there were chronic obstructive pulmonary disease and peripheral atherosclerotic disease in one patient. The basic characteristics of the patient are shown in Table 1.

Table 1: Basic characteristics of the patients

All patients who were scheduled to undergo endovascular stent graft implantation in our clinic were subjected to contrast-enhanced computed tomography (CT) angiography with 1.5 cm section as a standard procedure. Detailed evaluation of the structure of the aneurysm and the state of the major lateral branches from the aneurysm were made on CT angiography. Aortic diameter, wall calcification, the presence of thrombus in the vascular lumen, the length and angulation of the aneurysm neck where the stent was to be placed were calculated. Examination of the iliac and femoral arteries was also performed with regards to the type and size of the graft according to the state of entry suitability. The healthy vessel placement site proximal and distal to the grafts were measured and graft diameter was determined as more than 20% of the diameter.

Complex thoracoabdominal aortic aneurysm with major lateral branch involvement was reported in all of six patients in this study. Four of the patients were identified as Type 2 according to Crawford calcification, and two as Type 4. Furthermore, two patients had Type B dissection according to Stanford classification, while biiliac artery aneurysm in two patients, left iliac artery aneurysm in one patient, and severe stenosis in the right iliac artery in one patient was reported. All of the aneurysms were fusiform. An endovascular intervention was scheduled because of the high mortality and morbidity rate associated with the surgery to be performed. Conventional stent grafts were preferred in aneurysms with no major lateral branch involvement and in the presence of dissection, while multilayer flow modulator stents were preferred for patients with major lateral branches within or near the aneurysmal sac. Cardiatis MFM stents (Cardiatis, Isnes, Belgium) were used in all patients while Endologix AFX abdominal bifurcated stent graft (Endologix, Inc., Irvine, CA, USA) were used in five patients. On the other hand, two patients were treated with Endologix AFX proximal-distal extension tube stent graft, one patient with Jotec E-vita thoracal tube stent graft (Jotec AG, Hechingen, Germany) and two patients with Bolton relay thoracic tube stent graft (Bolton Medical Inc. Sunrise, FL, USA) (Table 2).

Table 2: Diagnosis of patients, stents and the grafts used

After informing the patients about the procedures to be performed and obtaining written consents, the surgical operation was carried out after providing the necessary sterilization and operating environment in the angiography unit. All procedures were performed under local anesthesia and sedation via the femoral arteries.

Postoperative follow-ups of the patients were performed at 1, 3, 6 and 12 months. By the third month, endovascular stents were also evaluated by CT angiography.

Patients treated with combined procedures:
Patient 1
Angiographic diagnosis: Type 2 aneurysm extending to a diameter of 65 mm at its widest point + biiliac aneurysm + Type B dissection extending from the left subclavian artery to about 2 cm proximal to the celiac artery (CA).

Procedure performed: J otec E -Vita Thoracic, a 38 mm in diameter and 23 cm long thoracic graft-coated stent (1 piece) from the left main femoral artery, was positioned and opened at the level of the left subclavian artery. An Endologix graft-coated bifurcated stent with code number BA25-60/I16-40 (abdominal diameter 25 mm, iliac diameter 16 mm, abdominal length 60 mm, iliac length 40 mm) (1 piece) was positioned. Aortic extension (1 piece) with code number Endologix A25-25/C95-O20 (25 mm in diameter, 95 mm in length and proximal 20 mm bare metal) was placed through the implanted main trunk to the level of the renal arteries. Cardiatis thoracoabdominal MFM (35 mm x 100 mm, 1 piece) stent with code number CTMS35100, including CA, superior mesenteric artery (SMA) and bilateral renal arteries, between the abdominal and thoracic stent grafts (including the two grafts) placement was made. An Endologix graft-coated stent with code number I20-13/C88F SA (total length 88 mm, proximal diameter 20 mm, distal diameter 13 mm) and iliac extension were placed in the left iliac artery (Figure 1a, b).

Figure 1: Computed tomography angiography images of patient number one (a) before surgery, and (b) after surgery. Axial section aortic diameter.
Level a: 65 mm; Level b: 42 mm; Level c: 55 mm.

Patient 2
Angiographic diagnosis: Type 2 aneurysm extending a diameter of 56 mm at its widest point + severe stenosis in the right common iliac artery.

Procedure performed: Bolton 36-32 mm, in a tapered structure, a 15 cm long (1 piece) thoracic graft-coated stent was positioned about 4-5 cm distal to the left subclavian artery. Endologix graft-coated bifurcated stent (1 piece) was placed with code number BA28-100/I20-40 (abdominal diameter 28 mm, iliac diameter 20 mm, abdominal length 100 mm, iliac length 40 mm). A cardiatis thoracoabdominal 35¥200 mm stent (1 piece) with code number MFM CTMS35200, which included CA, SMA and bilateral renal arteries was placed between the thoracic and abdominal stent grafts (including these two grafts). The right common iliac bifurcation level was dilated with an 8¥40 mm balloon.

Patient 3
Angiographic diagnosis: T ype 2 a neurysm extending a diameter of 55 mm at its widest point + Type B dissection.

Procedure performed: A B olton 1 5 c m i n l ong thoracic graft-coated tube stent (1 piece) (the widest area of the aneurysm and including the location of the tear in the intima of the dissection) with 32 mm diameter and 100 mm long tube graft structure, was opened by positioning a tube stent approximately 10 cm distal to the left subclavian artery. A cardiatis thoracoabdominal 40¥150 mm stent (1 piece) with code number MFM CTMS40150, was placed 5 cm proximal to the bifurcation level including CA, SMA, and bilateral renal arteries to oversize the inserted thoracic tube stent graft 2 cm distal to graft (Figure 2a, b).

Figure 2: Computed tomography angiography images of patient number three (a) before surgery, and (b) after surgery. Axial section aortic diameter.
Level a: 38 mm; Level b: 55 mm; Level c: 27 mm.

Patient 4
Angiographic diagnosis: T ype 4 a neurysm extending a diameter of 78 mm at its widest point + left iliac aneurysm.

Procedure performed: A n E ndologix g raft-coated bifurcated stent (1 piece) was placed with code number BA25-80/I16-55 (abdominal diameter 25 mm, iliac diameter 16 mm, abdominal length 80 mm, iliac length 55 mm).

A Cardiatis thoracoabdominal 35¥100 mm stent (1 piece) with code number MFM CTMS35100 was placed from the point of the main trunk extending proximally from CT to the aortic bifurcation level, and including the CA, SMA, and bilateral renal arteries.

Patient 5
Angiographic diagnosis: T ype 2 a neurysm extending a diameter of 58 mm at its widest point.

Procedure performed: A Bolton Relay tube stent graft (1 piece) 38 mm in diameter and 150 mm in length was positioned at the level of the left subclavian artery. An Endologix graft-coated bifurcated stent (1 piece) was placed with code number BA28-80/I20-40 (abdominal diameter 28 mm iliac diameter 20 mm abdominal length 80 mm iliac length 40 mm). An aortic extension (1 piece) with code number Endologix A34-34/C80-020V (diameter 34 mm, length 80 mm, and a 20 mm bare metal proximal portion) was placed through the main trunk to the level of the renal arteries. Cardiatis thoracoabdominal MFM (40 mm diameter and 150 mm long, 1 piece) stent with code number CTMS40150, was placed between the abdominal and thoracic stent grafts (including CA-SMA-Renal arteries).

Patient 6
Angiographic diagnosis: Type 4 aneurysm extending a diameter of 78 mm at its widest point + a biiliac aneurysm.

Procedure performed: An Endologix graft-coated bifurcated stent (1 piece) was placed with code number BA28-80/I20-40 (abdominal diameter 28 mm, iliac diameter 20 mm, abdominal length 80 mm, iliac length 40 mm). A cardiatis thoracoabdominal MFM 35¥150 mm stent (1 piece) with code number CTMS35150, was placed from the point of the main trunk extending proximally from CA to the aortic bifurcation level (including CA-SMA-Renal arteries).

Bulgular

Procedures were successfully completed in all six male patients. The mean duration of the procedure was 85 minutes, while the mean hospital stay was 6.5 days. Patients were followed-up for an average of 12 months (range 6-18 months) with regards to clinical event development. No case of mortality was reported during this period (Table 3).

Table 3: Procedure-related results (n=6)

A Type 1 leak occurred during operation in one patient. The bifurcated stent which was placed on the abdominal aorta was the proximal end of the graft. Placement of an aortic stent graft extension was made during the procedure, and the leak was observed to be completely corrected during follow-up.

One patient was reported to have an elevated creatinine level (2.1 mg/dL) on the second day after the procedure. There was no need for dialysis, and renal functions were completely normal by the seventh day. No complications were reported in the other patients during or after the procedure. All of the patients were discharged with 100 mg aspirin/day and 75 mg clopidogrel/day therapy.

No complications were reported during follow-ups conducted on postoperative 1st, 3rd, 6th and 12th month and on the CT angiography performed in the third month.

Tartışma

Multilayer flow modulator stents are a new technology-type of stents used in the treatment of thoracoabdominal aortic aneurysms. Although there are publications in the literature on the mid- and short-term outcomes of these stents, only a few publications have been reported on their use together with other conventional stent grafts.[6,7]

Surgical treatment of thoracoabdominal aortic aneurysms and Type B aortic dissections is a high intervention even in experienced centers, and the mean intraoperative mortality rate is reported at 5% and can rise up to 50% in the presence of a rupture.[8,9] Although surgical procedures are the gold standard in the treatment of these diseases, endovascular methods have become the first choice in recent years.[10-12] With the development of new technologies, complex aneurysms have become endovascularly treatable, with increasing rates of complications and technical failure.[13,14]

Current treatment of thoracoabdominal aortic aneurysms is associated with a reduced mortality and morbidity rate. The most dangerous complications include rupture of the aneurysm, paraplegia and organ failure which may be associated with blockage of major branches. Flow in the major lateral branches is mechanically sustained when the aneurysm is isolated with Chimney and fenestrated stent grafts developed to provide reduced states of these conditions. However, the application of these stents is very difficult and the clinical results are not satisfactory.[5,15] On the other hand, MFM stents, which have recently been developed and introduced into clinical practice, are easier to apply and do not require patient-specific preliminary preparations. The short and mid-term clinical results are also encouraging.[5,6]

Three studies using different types of stent grafts for thoracic aortic pathologies demonstrated that the 30 days mortality rate was 3.8 to 12.3%, while the rate of paraparesis/paraplegia was 2.5 to 5.5%, stroke: 2.8 to 8% and leakage: 11 to 12%.[16-18] In our study, no mortality was reported and the most important complications including paraplegia, stroke and major lateral branch blockage, did not develop. We attribute this to the fact that we used MFM stents in the region of the aneurysm with major lateral branches; however, our study sample was relatively small and we emphasize that this should be supported by more extensive studies.

The most common reported complication of endovascular treatment is leakage and varies between 10% and 50% in various studies. In the treatment of Type 1 and Type 3 leakages, a new graft should immediately be applied during the procedure. Type 2 leakage should be treated in cases where they the last for six months since they may cause dilation and rupture of the aneurysm. Type 4 leakage is occasionally caused by new generation stents.[19,20] In our study, Type 1 leakage was reported only in one patient and was corrected by the additional tube graft placed during the procedure.

Endovascular treatment has become the preferred method of treatment for complicated Type B aortic dissections due to the high morbidity and mortality risks observed with conventional open surgery. The main objective is to cover the primary tear site with the stent-graft to direct blood flow into the real lumen and to reduce compression of the false lumen to the real lumen in order to provide antegrade flow to the main branch.[21,22] Evaluation of the early stage results of endovascular stent graft application in the study published by Dias et al.[23] on acute complicated Type B aortic dissection, demonstrated a mortality rate of 16%. Stent-graft-related was reported in two patients within the first 30 days, whereas four patients were reported to have died due to cardiac causes. Paraplegia was also reported in one patient, stroke in four patients while the neurologic complication rate was reported as 22.7% (n=5). Sajid et al.,[10] in their study reported that the primary tear site was successfully closed in 97.1% of patients using conventional stent grafts, with a one-month mortality rate of 2.8%. Furthermore, a 2.8% stroke, 2.8% permanent renal failure and 2.8% spinal cord ischemia rates were reported.[24]

Stent grafts are widely used in Type B dissections, whereas there is very limited data in the literature on the use of MFM stents. In one of these studies which were published in 2011, Chocron et al.[25] successfully applied MFM stent on Type B dissection. The authors suggested that in the treatment of thoracoabdominal aortic aneurysms, MFM stents translate turbulent flow in the aneurysm into laminar flow, cause thrombosis in the aneurysm and that this may also be applicable to chronic aortic dissections. The authors also commented that if in the presence of multiple re-entries during chronic dissections, there would be turbulent blood flow due to the small nature of these re-entries, and that MFM stents could, therefore, be used.

In our study, the aneurysm was accompanied by Type B dissection in two patients. The main site of the tear in the intima of the dissection was distal to the left subclavian artery in both patients. We used tube stent grafts to cover this area and false lumen from the true lumen of the site. We do not prefer multilayer flow modulator stents because of the possibility of providing continuous flow into the false lumen and because there was not enough data on this subject in the literature. Complete recovery was achieved in both of our patients after the procedure and there were no reported complications.

Another reason for the use of multilayer flow modulator stents in combination with other stent grafts is the fact that the cost of MFM stents is significantly higher in Turkey than the other stent grafts, and the cost of combined use is low. Despite the cost, the MFM stents were preferred because flow in the major branches persisted, from within or near the aneurysm at the exit of the major branches, and especially at the levels of the aneurysms into the CA, SMA, and renal arteries.

Our study has some limitations, which include a relatively few patient groups, such as of six patients, and the 12-month mid-term results devoid of any longterm results. Although we did not have any mortality or serious complications in any of our patients, we suggest that careful patient selection is necessary when using MFM stents.

In conclusion, we think that the combined use of different structural features and stents increases the chances of success and decreases the complication rates in complex aortic aneurysms, depending on the type of stent selected according to characteristics of the aneurysm.

Declaration of conflicting interests
The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Funding
The authors received no financial support for the research and/or authorship of this article.

Kaynaklar

1) Erbel R, Aboyans V, Boileau C, Bossone E, Bartolomeo RD, Eggebrecht H, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2873-926.

2) Najibi S, Terramani TT, Weiss VJ, Mac Donald MJ, Lin PH, Redd DC, et al. Endoluminal versus open treatment of descending thoracic aortic aneurysms. J Vasc Surg 2002;36:732-7.

3) Makaroun MS, Dillavou ED, Wheatley GH, Cambria RP. Five-year results of endovascular treatment with the Gore TAG device compared with open repair of thoracic aortic aneurysms. J Vasc Surg 2008;47:912-8.

4) Koncar I, Tolic M, Ilic N, Cvetkovic S, Dragas M, Cinara I, et al. Endovascular aortic repair: first twenty years. Srp Arh Celok Lek 2012;140:792-9.

5) Debing E, Aerden D, Gallala S, Vandenbroucke F, Van den Brande P. Stenting complex aorta aneurysms with the Cardiatis multilayer flow modulator: first impressions. Eur J Vasc Endovasc Surg 2014;47:604-8.

6) Pane B, Spinella G, Perfumo C, Palombo D. A Single- Center Experience of Aortic and Iliac Artery Aneurysm Treated with Multilayer Flow Modulator. Ann Vasc Surg 2016;30:166-74.

7) Sultan S, Kavanagh E, Stefanov F, Sultan M, Costache V, Elhelali A, et al. Streamliner Multilayer Flow Modulator stents as a therapeutic option in the management of complex thoraco-abdominal aortic pathology report from Global SMFM Registry. J Indian Coll Cardiol 2016;6:77-84.

8) Svensson LG, Crawford ES. Cardiovascular and Vascular Disease of the Aorta. Philadelphia: WB Saunders Co; 1997.

9) Choksy SA, Wilmink AB, Quick CR. Ruptured abdominal aortic aneurysm in the Huntingdon district: a 10-year experience. Ann R Coll Surg Engl 1999;81:27-31.

10) Sajid MS, Desai M, Haider Z, Baker DM, Hamilton G. Endovascular aortic aneurysm repair (EVAR) has significantly lower perioperative mortality in comparison to open repair: a systematic review. Asian J Surg 2008;31:119-23.

11) Greenhalgh RM, Brown LC, Kwong GP, Powell JT, Thompson SG. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet 2004;364:843-8.

12) Uğur M, Alp İ, Arslan G, Şenay Ş, Selçuk İ, Selçuk A, et al. Endovascular and hybrid treatment in the management of vascular disease: experience of a cardiovascular surgery department. Turk Gogus Kalp Dama 2012;20:230-42.

13) Gleason TG. Endoleaks after endovascular aortic stentgrafting: impact, diagnosis, and management. Semin Thorac Cardiovasc Surg 2009;21:363-72.

14) Hughes GC, McCann RL. Hybrid thoracoabdominal aortic aneurysm repair: concomitant visceral revascularization and endovascular aneurysm exclusion. Semin Thorac Cardiovasc Surg 2009;21:355-62.

15) Moulakakis KG, Mylonas SN, Avgerinos E, Papapetrou A, Kakisis JD, Brountzos EN, et al. The chimney graft technique for preserving visceral vessels during endovascular treatment of aortic pathologies. J Vasc Surg 2012;55:1497-503.

16) Kwolek CJ, Fairman R. Update on thoracic aortic endovascular grafting using the Medtronic talent device. Semin Vasc Surg 2006;19:25-31.

17) Wheatley GH, Gurbuz AT, Rodriguez-Lopez JA, Ramaiah VG, Olsen D, Williams J, et al. Midterm outcome in 158 consecutive Gore TAG thoracic endoprostheses: single center experience. Ann Thorac Surg 2006;81:1570-7.

18) Zipfel B, Buz S, Hammerschmidt R, Krabatsch T, Duesterhoeft V, Hetzer R. Early clinical experience with the E-vita thoracic stent-graft system: a single center study. J Cardiovasc Surg (Torino) 2008;49:417-28.

19) Chuter TA, Faruqi RM, Sawhney R, Reilly LM, Kerlan RB, Canto CJ, et al. Endoleak after endovascular repair of abdominal aortic aneurysm. J Vasc Surg 2001;34:98-105.

20) Golzarian J, Maes EB, Sun S. Endoleak: treatment options. Tech Vasc Interv Radiol 2005;8:41-9.

21) Parker JD, Golledge J. Outcome of endovascular treatment of acute type B aortic dissection. Ann Thorac Surg 2008;86:1707-12.

22) Eggebrecht H, Nienaber CA, Neuhäuser M, Baumgart D, Kische S, Schmermund A, et al. Endovascular stent-graft placement in aortic dissection: a meta-analysis. Eur Heart J 2006;27:489-98.

23) Dias NV, Sonesson B, Koul B, Malina M, Ivancev K. Complicated acute type B dissections--an 8-years experience of endovascular stent-graft repair in a single centre. Eur J Vasc Endovasc Surg 2006;31:481-6.

24) Szeto WY, McGarvey M, Pochettino A, Moser GW, Hoboken A, Cornelius K, et al. Results of a new surgical paradigm: endovascular repair for acute complicated type B aortic dissection. Ann Thorac Surg 2008;86:87-93.

25) Chocron S, Vaislic C, Kaili D, Bonneville JF. Multilayer stents in the treatment of thoraco-abdominal residual type B dissection. Interact Cardiovasc Thorac Surg 2011;12:1057-9.